Top Suppliers:I want be here
Related CAS#:
23113-43-1 1406-14-0
6138-79-0 127228-87-9
143851-98-3 929-73-7
65546-09-0 1135280-78-2
56-99-5 1406-02-6

23113-43-1

23113-43-1 structure
23113-43-1 structure
  • Name: GUANABENZ HYDROCHLORIDE
  • Chemical Name: 2-[(E)-(2,6-dichlorophenyl)methylideneamino]guanidine,hydrochloride
  • CAS Number: 23113-43-1
  • Molecular Formula: C8H9Cl3N4
  • Molecular Weight: 267.543
  • Catalog: Signaling Pathways GPCR/G Protein Adrenergic Receptor
  • Create Date: 2016-04-22 09:29:04
  • Modify Date: 2024-01-29 18:07:06
  • Guanabenz (hydrochloride) is an oral α-2-adrenoceptor agonist, has antihypertensive effect and antiparasitic activity. Guanabenz (hydrochloride) interferes ER stress-signalling and has protective effects in cardiac myocytes. Guanabenz (hydrochloride) also is used for the research of high blood pressure(equivalent).
Name 2-[(E)-(2,6-dichlorophenyl)methylideneamino]guanidine,hydrochloride
Synonyms Carbonohydrazonic diamide, N''-[(1E)-(2,6-dichlorophenyl)methylene]-, hydrochloride (1:1)
N''-[(E)-(2,6-Dichlorophenyl)methylene]carbonohydrazonic diamide hydrochloride (1:1)
Guanabenz hydrochloride
Guanabenz HCl
Guanoxabenzhydrochloride
WY-8678 hydrochloride
Description Guanabenz (hydrochloride) is an oral α-2-adrenoceptor agonist, has antihypertensive effect and antiparasitic activity. Guanabenz (hydrochloride) interferes ER stress-signalling and has protective effects in cardiac myocytes. Guanabenz (hydrochloride) also is used for the research of high blood pressure(equivalent).
Related Catalog
In Vitro Guanabenz (hydrochloride) (0.5–50 μM, 24 h) is treated with increasing concentrations for 24 hours not affect cell viability. Guanabenz (hydrochloride) (0.5–50 μM, 24 h) alone not affects the UPR targets, neither on mRNA or protein level nor the phosphorylation status of eIF2a. Guanabenz also not induces GADD34 or the constitutively active form CReP. Guanabenz (hydrochloride) (0.5–50 μM, 24 h) alone not induces ER stress in neonatal rat cardiomyocytes[1]. Cell Viability Assay[1] Cell Line: Neonatal rat cardiac myocytes (NRCM) Concentration: 0.5–50 μM Incubation Time: 24 h Result: Did not affect cell survival. RT-PCR[1] Cell Line: Neonatal rat cardiac myocytes (NRCM) Concentration: 0.5–50 μM Incubation Time: 24 h Result: Did not affect levels of UPR targets. Western Blot Analysis[1] Cell Line: Neonatal rat cardiac myocytes (NRCM) Concentration: 0.5–50 μM Incubation Time: 24 h Result: Increased the levels of low panel concentration-dependent UPR targets proteins.
In Vivo Guanabenz (hydrochloride) (5 mg/kg/day; i.p.; for 3 weeks) can reproducibly reduce brain cyst burden. Guanabenz (hydrochloride) (5 mg /kg/d, i.p., oral; 10 mg/kg/d, gavage; for 3 weeks) reverses Toxoplasma-induced hyperactivity in latently infected mice. Guanabenz (hydrochloride) (100 and 320 μg/kg and 1 mg/kg, i.v., over a period of 5 min at intervals of 40 min) reduces sympathetic outflow, heart rate and blood pressure in debuffered cats[2][3]. Animal Model: BALB/cJ mice[2] Dosage: 5 mg/kg Administration: 5 mg/kg/day; i.p. ; for 3 weeks Result: Reduced the latent brain cysts in both male and female BALB/cJ mice. Animal Model: BALB/cJ mice[2] Dosage: 5 mg/kg; 10 mg/kg Administration: 5 mg /kg/d, i.p., oral; 10 mg/kg/d, gavage; for 3 weeks Result: Reversed parasite-induced hyperactivity to near-baseline levels. Animal Model: Cats[3] Dosage: 100 and 320 μg/kg and 1 mg/kg Administration: 100 and 320 μg/kg and 1 mg/kg, i.v., over a period of 5 min at intervals of 40 min Result: Declined markedly blood pressure and nerve activity.
References

[1]. Christiane Neuber, et al. Guanabenz interferes with ER stress and exerts protective effects in cardiac myocytes. PLoS One. 2014 Jun 3;9(6):e98893.

[2]. Jennifer Martynowicz, et al. Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing Neuroinflammation. mBio. 2019 Apr 30;10(2):e00381-19.

[3]. T Baum, et al. Studies on the centrally mediated hypotensive activity of guanabenz. Eur J Pharmacol. 1976 May;37(1):31-44.
Boiling Point 405.7ºC at 760mmHg
Molecular Formula C8H9Cl3N4
Molecular Weight 267.543
Flash Point 199.1ºC
Exact Mass 265.989288
PSA 74.26000
LogP 3.80330
Vapour Pressure 8.63E-07mmHg at 25°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MV1692300
CHEMICAL NAME :
Hydrazinecarboximidamide, 2-(2,6-dichlorobenzylidene)-, hydrochloride
CAS REGISTRY NUMBER :
23113-43-1
LAST UPDATED :
199201
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C8-H8-Cl2-N4.Cl-H
MOLECULAR WEIGHT :
267.56
WISWESSER LINE NOTATION :
MUYZMNU1R BG FG &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement Behavioral - ataxia
REFERENCE :
YKKZAJ Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- Volume(issue)/page/year: 95,966,1975
HS Code 2928000090
HS Code 2928000090
Summary 2928000090 other organic derivatives of hydrazine or of hydroxylamine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

Chemsrc provides CAS#:23113-43-1 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 23113-43-1 | Chemsrc address: https://www.chemsrc.com/en/baike/509883.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved